Proviva Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $30M

  • Investors
  • 9

Proviva Therapeutics General Information

Description

Developer of pharmaceutical technology platform intended for anti-tumor immunity. The company develops a prodrug technology platform that can achieve specific release of cytokines in the tumor microenvironment, enabling medical users improve the efficacy and safety of tumor treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 334 Edison Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 137
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 334 Edison Road, Pudong New Area
  • Shanghai, 201210
  • China
+86 137

Proviva Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proviva Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A1) 01-Dec-2025 $30M Completed Generating Revenue
3. Accelerator/Incubator 01-Dec-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Mar-2023 $18M $18M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Startup
To view Proviva Therapeutics’s complete valuation and funding history, request access »

Proviva Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proviva Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Changrong Capital Venture Capital Minority
Hankang Capital Growth/Expansion Minority
HSG (Hong Kong) Venture Capital Minority
OrbiMed Growth/Expansion Minority
Westfield BioVentures Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Proviva Therapeutics FAQs

  • When was Proviva Therapeutics founded?

    Proviva Therapeutics was founded in 2019.

  • Where is Proviva Therapeutics headquartered?

    Proviva Therapeutics is headquartered in Shanghai, China.

  • What is the size of Proviva Therapeutics?

    Proviva Therapeutics has 2 total employees.

  • What industry is Proviva Therapeutics in?

    Proviva Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Proviva Therapeutics a private or public company?

    Proviva Therapeutics is a Private company.

  • What is Proviva Therapeutics’s current revenue?

    The current revenue for Proviva Therapeutics is .

  • How much funding has Proviva Therapeutics raised over time?

    Proviva Therapeutics has raised $48M.

  • Who are Proviva Therapeutics’s investors?

    Changrong Capital, Hankang Capital, HSG (Hong Kong), OrbiMed, and Westfield BioVentures are 5 of 9 investors who have invested in Proviva Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process